| Team-NB-List-PositionPapers-20251216 |
16/12/2025 |
| Team-NB-PositionPaper-Annex-VII-V1-20251216 |
16/12/2025 |
| Team-NB-PositionPaper-Annex-VII-V1-20251216-ExecSum |
16/12/2025 |
| Team-NB-PositionPaper-IVD-SARS-CoV-2-down-classification-V1-20251212 |
12/12/2025 |
| Team-NB-PositionPaper-MDR-Application-and-appropriate-surveillance-Transfer-agreement-V1-20251022 |
22/10/2025 |
| Team-NB-PositionPaper-IVDR-Significant-changes-V2 |
22/10/2025 |
| Team-NB-PositionPaper-BPG-IVDR-V2-20250903 |
03/09/2025 |
| Team-NB-PositionPaper-Ophan-IVDR-Medical-Devices-V1-20250717 |
17/07/2025 |
| Team-NB-PositionPaper-Software-Qualification-under-the-IVDR-V2-20250627 |
27/06/2025 |
| Team-NB-PositionPaper-IVDR-Certification-Process-Consensus-Document-V1-20250409 |
09/04/2025 |
| Team-NB-PositionPaper-EU-AI-Act-V2-20250409 |
09/04/2025 |
| Team-NB-PositionPaper-BPG-TechnicalDocEU-MDR-2017-745-V3-20250409 |
09/04/2025 |
| Team-NB-PositionPaper-MDR-Certification-Process-Consensus-Document-20241218 |
18/12/2024 |
| Joint-Team-NB-IG-NB-PositionPaper-AI-in-MD-Questionnaire-V1.1 |
10/12/2024 |
| Team-NB-PositionPaper-IVD-Transfer-Agreement-20240911 |
11/09/2024 |
| Team-NB-IVDConfirmationLetterTemplate-V2-20240710 |
10/07/2024 |
| Team-NB-PositionPaper-TransferAgreement-v02-20240702-with-instructions |
02/07/2024 |
| Team-NB-PositionPaper-Classification-of-SARS-Cov2 |
02/02/2024 |
| Team NB PositionPaper Lifetime Medical Device |
27/11/2023 |
| Team-NB PositionPaper LegacyMD Surveillance Transfer Agreement V1 |
11/08/2023 |
| Team-NB PositionPaper MDR Transition Timelines Notified Body Capacity V1 |
10/08/2023 |
| Team-NB PositionPaper NB-ConfirmationLetterEU2023-607 V2 |
10/07/2023 |
| Team-NB-PositionPaper-HybridAudits-V2-20230516 |
16/05/2023 |
| TEAM-NB Position in Response to MDCG 2022-14 Item Number 17 – ‘Certificates under Conditions’ |
11/11/2022 |
| Team-NB PositionPaper Voluntary Transfer Agreement V1 20221005 |
05/10/2022 |
| Team-NB-PositionPaper-CyberSecurity-V1-20221005 |
05/10/2022 |
| Team-NB-PositionPaper-Off-LabelUse-V1-20221005 |
05/10/2022 |
| Team-NB-PositionPaper-ConfAssessment-Multiplexassays-V1-20220714 |
14/07/2022 |
| Team-NB-PositionPaper-ModificationsSamplingPlan-V1-20220128 |
28/01/2022 |
| Team-NB-PositionPaper-on-MDR_IVDR-Implementation-V3-20211201 |
01/12/2021 |
| Team-NB-PositionPaper-Article117-NB-Opinion-Template-V120211006 |
06/10/2021 |
| Team-NB-PositionPaper-Artificial-Intelligence-V1-20211006 |
06/10/2021 |
| Team-NB-PositionPaper-ImplantCard-20210720 |
20/07/2021 |
| Team-NB-PositionPaper-ClassD-conformity assessment-V4.4-20210519 |
19/05/2021 |
| Team-NB-PositionPaper-Art117-Substantial-Changes-DrugDeviceCombination-20211221 |
21/12/2020 |
| Team-NB-PositionPaper-RemoteAudits-V1-20201118 |
18/11/2020 |
| Team-NB-PositionPaper-TCP-V1-20200722 |
22/07/2020 |
| Team-NB-PositionPaper-Documentation-Requirements-Article117-V1-20200401 |
01/04/2020 |